RE: Vlad clinical commercial & financial strategy25 Nov 2025 09:01
Like I said the other day , the mass selling is due to how we fund our future, which atm looks like it will be by massive dilution. But one jv or interest from big pharmar and this all turnes on its head and we will be way above Β£30.